<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Saudi J Anaesth</journal-id><journal-id journal-id-type="publisher-id">SJA</journal-id><journal-title-group><journal-title>Saudi Journal of Anaesthesia</journal-title></journal-title-group><issn pub-type="ppub">1658-354X</issn><issn pub-type="epub">0975-3125</issn><publisher><publisher-name>Medknow Publications</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21957410</article-id><article-id pub-id-type="pmc">3168348</article-id><article-id pub-id-type="publisher-id">SJA-5-295</article-id><article-id pub-id-type="doi">10.4103/1658-354X.84105</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>A comparison of the sedative, hemodynamic, and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dave</surname><given-names>Jaydev</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Vaghela</surname><given-names>Sandip</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><italic>Department of Anaesthesiology, M. P. Shah Medical College, Jamnagar, Gujarat, India</italic></aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Jaydev K. Dave, 11/3, Patel Colony, Bilva-Patra, Jamnagar &#x02013; 361 008, Gujarat, India. E-mail: <email xlink:href="dr.sandy4u@yahoo.co.in">dr.sandy4u@yahoo.co.in</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Sep</season><year>2011</year></pub-date><volume>5</volume><issue>3</issue><fpage>295</fpage><lpage>299</lpage><permissions><copyright-statement>Copyright: &#x000a9; Saudi Journal of Anaesthesia</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Aim:</title><p>To compare the sedative, hemodynamic, and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging procedures.</p></sec><sec id="st2"><title>Methods:</title><p>Sixty children between the age of 1 to 7 years were randomly distributed into two groups: The dexmedetomidine (D) group received 1 <italic>&#x003bc;</italic>g/kg initial dose followed by continuous infusion of 0.5 <italic>&#x003bc;</italic>g/kg/h, and the propofol group (P) received 3 mg/kg initial dose, followed by a continuous infusion of 100 <italic>&#x003bc;</italic>g/kg/min. Inadequate sedation was defined as difficulty in completing the procedure because of the child's movement during magnetic resonance imaging. Mean arterial pressure (MAP), heart rate, peripheral oxygen saturation, and respiratory rate (RR) were recorded during the study.</p></sec><sec id="st3"><title>Result:</title><p>The onset of sedation, recovery, and discharge time were significantly shorter in group P than in group D. MAP, heart rate, and RR decreased during sedation from the baseline values in both groups. MAP and RR were significantly lower in group P than in group D during sedation. Dexmedetomidine and propofol provided adequate sedation in most of the children.</p></sec><sec id="st4"><title>Conclusion:</title><p>We conclude that although propofol provided faster anesthetic induction and recovery times, it caused hypotension and desaturation. Dexmedetomidine could be an alternative, reliable sedative drug to propofol in selected patients.</p></sec></abstract><kwd-group><kwd><italic>Dexmedetomidine</italic></kwd><kwd><italic>magnetic resonance imaging</italic></kwd><kwd><italic>propofol</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Sedation is frequently necessary for children between 1 to 7 years of age undergoing magnetic resonance imaging (MRI) to ensure examinations that is of diagnostic quality. Because procedural sedation is unable to guarantee patient compliance in these cases, a deeper level of sedation is required.[<xref ref-type="bibr" rid="ref1">1</xref><xref ref-type="bibr" rid="ref2">2</xref>] The success of sedation for MRI has typically been measured by two factors: the safety of the sedation procedure (lack of adverse events); and the effectiveness of the procedure (successful completion of the diagnostic examination).[<xref ref-type="bibr" rid="ref3">3</xref>] Sedation of children for MRI is usually associated with inadequate or failed sedation because of difficulty in having patients motionless while maintaining hemodynamic and respiratory stability. Also, limited access to the patient may pose a safety risk during MRI examination.[<xref ref-type="bibr" rid="ref1">1</xref><xref ref-type="bibr" rid="ref4">4</xref><xref ref-type="bibr" rid="ref12">12</xref>] Therefore, appropriate drugs need to be selected, administered, and titrated to achieve these objectives.[<xref ref-type="bibr" rid="ref5">5</xref>]</p><p>Dexmedetomidine is a potent, highly selective &#x003b1;2 adrenoreceptor agonist having a distribution half-life of approximately 8 min and a terminal half-life of 3.5 h.[<xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref7">7</xref>] At therapeutic doses, dexmedetomidine provides profound levels of sedation without affecting cardiovascular and respiratory stability.[<xref ref-type="bibr" rid="ref7">7</xref>&#x02013;<xref ref-type="bibr" rid="ref9">9</xref>] There is a significant interest in the use of propofol for sedation in children in the MRI setting, because of its predictability, rapid onset, and offset of action.[<xref ref-type="bibr" rid="ref2">2</xref><xref ref-type="bibr" rid="ref10">10</xref><xref ref-type="bibr" rid="ref11">11</xref>] There is no study comparing dexmedetomidine and propofol sedation for use in children undergoing MRI.</p></sec><sec sec-type="methods" id="sec1-2"><title>METHODS</title><p>After local Institutional Ethics Committee approval and written parental consent, American Society of Anesthesiologists (ASA) physical status I-II children aged between 1&#x02013;7 years undergoing MRI were included in this randomized and prospective study. The clinical data for use of propofol less than 1 year is controversial and children above age of 8 years can be sedated with both the drugs, but in our set, upto 70% of MRI comprises age group between 1 to 7 years. Patients with known heart, lung, and neurological disease, central nervous system or extremity trauma, and airway abnormalities were excluded from the study. Patients with known allergies to the study drugs or patients having received any study drug in the last 30 days were also excluded. Children older than 3 years of age were Nil per oral (NPO) for solids and milk for at least 8 h and children 1&#x02013;3 years of age were NPO for solids and milk for 6 h. All the children were allowed to take clear liquids up until 2 h before the beginning. The pre sedation behavior was assessed on a four point scale by an anesthesiologist as following:</p><p>1 = Calm, cooperative;</p><p>2 = Anxious but reassurable;</p><p>3 = Anxious and not reassurable; and</p><p>4 = Crying or resisting</p><p>Categories 1 and 2 were called &#x02018;un distressed behavior&#x02019;, while categories 3 and 4 were defined as &#x02018;distressed behavior&#x02019;.</p><p>Baseline values of heart rate, respiratory rate, SpO2, and mean arterial blood pressure were recorded upon arrival of the unpremedicated children to the preparation room before the 22-gauge or 24-gauge venous cannula was inserted into the dorsum of the hand. All the children were induced in recovery room nearer to the MRI room. All the patients were inpatients and informed consent was obtained for sedation purpose for all the patients as per hospital ethics.</p><p>Patients were categorized in two groups &#x02013;</p><p>Group 1: dexmedetomidine group (<italic>n</italic>=30), Group D.</p><p>Group 2: propofol group (<italic>n</italic>=30), Group P.</p><p>Solutions of dexmedetomidine Mcleod laboratories, Dexem, Themis Medicare Ltd. Haridwar, Uttarakhand, 1 ml at a concentration of 100 &#x003bc;g/ml, was diluted with 49 ml of normal saline to a concentration of 2 &#x003bc;g/ml. Propofol 1% profol, Claris laboratories, Profol, Claris Lifescience Ltd. Chacharvadi-vasna, Ahmedabad, Gujarat solution.</p><p>To reduce pain on propofol injection, 1 ml of 1% lignocaine xylocaine, Astrazeneca, Xylocard 2%, Astrazeneca Pharma India Ltd., Bangalore, Karnataka was administered intravenously before propofol administration. The initial dose of study drugs were administered for 10 min.</p><p>
<list list-type="bullet"><list-item><p>Inj. dexmedetomidine, 1 &#x003bc;g/kg, followed by 0.5 &#x003bc;g/kg/h; and</p></list-item><list-item><p>Inj. propofol, 3 mg/kg, followed by 100 &#x003bc;g/kg/min.</p></list-item></list>
</p><p>Sedation level was measured by Ramsay sedation scale every 10 min. The Ramsay scale assigns a score of 1-6 based on the level of sedation as follows:</p><p>1 = Anxious, agitated, and restless;</p><p>2 = Awake, but cooperative, tranquil, and oriented; and</p><p>3 = Responds to verbal commands only</p><p>Scores of 4 to 6 are used for sleeping patients and are graded according to response to loud noises or glabellar taps as follows:</p><p>4 = Brisk response;</p><p>5 = Sluggish response; and</p><p>6 = No response</p><p>Score of 3 was accepted as procedural sedation and score of 5 as deep sedation. Children were transferred and positioned on the scanning table with a shoulder roll under the neck (either a rolled up towel or sheet) after both a Ramsay score of 5 was achieved and hemodynamic and respiratory stability was ensured. If the score of 5 was not achieved after 25 min of sedation, the infusion rate of study drugs was increased from 0.5 to 0.7 &#x003bc;g/kg/h in group D; and from 100 to 150 &#x003bc;g/kg/min in group P for 5 min. We have used infusion in a pediatric infusion set and fixed to a stand just near to the machine. Inadequate sedation was defined as difficulty in completing the procedure as a result of the child's movement during MRI examination.</p><sec id="sec2-1"><title>Monitoring</title><p>Mean arterial blood pressure (MAP), heart rate (HR), peripheral oxygen saturation, and respiratory rate (RR) were monitored continuously at 5 min interval during the study by an anesthesiologist. BP instrument used was of hanging wall BP instrument from A To Z Medical Stores, Vile Parle, Mumbai, Maharashtra; SpO2- Tesla medical, Hyderabad, Andhra Pradesh. Patients were allowed to breathe spontaneously without an artificial airway during the procedure. Ventilator function was assessed by observation of respiratory activity. If the level of SpO2 decreased below 93% for 30 s, the imaging process would be interrupted and patient would be taken out of the MRI tunnel. After airway patency was assessed, neck was extended slightly and oxygen was administered via face mask, and the study drug infusion was discontinued temporarily.</p></sec><sec id="sec2-2"><title>Quality of MRI</title><p>MRI machine was of 1.5 Tesla, Siemens Medical Ltd, Ahmedabad, Gujarat.</p><p>Evaluated by the radiologist using a three- point scale:</p><p>1 = No motion;</p><p>2 = Minor movement; and</p><p>3 = Major movement necessitating another scan</p><p>At the end of the MRI, drug infusion was discontinued and patients were transferred to recovery room. The onset of sedation time was defined as the period of time between the beginning of study drug infusion and reaching Ramsey score of 5. Recovery time was accepted as period of time between discontinuation of infusion drug and reaching a Ramsey score of 2. Discharge time was defined as time interval between discontinuation of drug and discharge of children from hospital. Criteria for discharge were return of vital signs and the level of consciousness to baseline, and the ability to maintain a patent airway. Side effects like nausea, vomiting and dysphoria occurred during and after sedation were recorded.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>All of the 60 patients were categorized in two groups and obtained data were compared using paired &#x0201c;t&#x0201d; test and the level of significance was set at p- value of less than 0.05. The sample size was calculated using &#x003b1;=0.05 and &#x003b2;=0.2,hence power of the study is 80%.The patients&#x02019; demographics, pre sedation behavior score, and the duration, type, and quality of MRI procedure were not statistically different between the groups [<xref ref-type="table" rid="T1">Table 1</xref>]. Adequate sedation, as defined by quality of the examination, was obtained in all children in both the groups. Although, deep sedation (Ramsay score of 5) was obtained with the dexmedetomidine or propofol infusion before MRI examination. In group P, the onset of sedation, recovery, and discharge time were significantly shorter than in group D (<italic>P</italic>&#x0003c;0.05). The level of consciousness was the same in both groups at the time of discharge. The duration of drug infusion was not different between groups (<italic>P</italic>&#x0003c;0.05) [<xref ref-type="table" rid="T2">Table 2</xref>]. MAP, HR, and RR were not statistically different between groups before sedation. MAP and HR decreased significantly from baseline during sedation in both groups (<italic>P</italic>&#x0003c;0.001). HR at 10, 20, and 25 min was significantly more rapid in group P than in group D, and MAP at 10, 15, 20, 35 and 50 min was lower in group P than group D; however, these differences were not clinically significant. MAP in group P decreased below 20% from baseline only at 50 min. The RR was statistically significantly less in group P than group D but these differences were not clinically significant. Bradycardia was not observed in any child. The maximum decreases in MAP during sedation in groups D and P were 17 and 21%, where the maximum decrease in HR during sedation were 15 and 17%, respectively, and the maximum decreases in RR during sedation in groups D and P were 8 and 17%, respectively [<xref ref-type="table" rid="T3">Table 3</xref>]. No side effects such as nausea, vomiting, or dysphoria were observed in either group during or after sedation.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Patient characteristics, duration, type, and quality of magnetic resonance imaging procedures</p></caption><graphic xlink:href="SJA-5-295-g001"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Results of sedation and duration of study drug infusion</p></caption><graphic xlink:href="SJA-5-295-g002"/></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Hemodynamic and respiratory changes during study drug infusion</p></caption><graphic xlink:href="SJA-5-295-g003"/></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>Our results indicate that although both drugs prevented undesired movement in most of the children, propofol provided more rapid rates of induction, recovery, and discharge but dexmedetomidine better preserved MAP and RR and did not cause any de saturation. All demographic data were comparable in both the groups with respect to age, weight, and sex. The mean duration of MRI was not significant in both the groups [<xref ref-type="table" rid="T1">Table 1</xref>]. Previous studies indicate that infusion doses of dexmedetomidine (0.1&#x02013; 0.7 &#x003bc;g/kg/h) have provided effective sedation.[<xref ref-type="bibr" rid="ref13">13</xref>&#x02013;<xref ref-type="bibr" rid="ref16">16</xref>] Various studies[<xref ref-type="bibr" rid="ref2">2</xref><xref ref-type="bibr" rid="ref10">10</xref><xref ref-type="bibr" rid="ref11">11</xref>] demonstrated that infusion of propofol at a rate of 100&#x02013;150 &#x003bc;g/kg/min effectively prevents at least 90% of children from moving during elective MRI. These doses are similar to our propofol doses, and our results were consistent with these studies.</p><p>In our study, propofol's onset, discharge, and recovery times were faster as compared to dexmedetomidine group [<xref ref-type="table" rid="T2">Table 2</xref>], as described in previously published studies.[<xref ref-type="bibr" rid="ref2">2</xref><xref ref-type="bibr" rid="ref9">9</xref><xref ref-type="bibr" rid="ref11">11</xref><xref ref-type="bibr" rid="ref17">17</xref>] Adequate sedation was obtained with dexmedetomidine and propofol in most of the children. In our study, the faster onset of sedation time could be explained by the fact that we accepted the Ramsay score of 5 as the time to onset of sedation as opposed to the accepted Ramsay score in our previous study. Although the advantage of dexmedetomidine was hemodynamic stability, there are contradictory results related to its hemodynamic effects in the literature.[<xref ref-type="bibr" rid="ref7">7</xref>&#x02013;<xref ref-type="bibr" rid="ref9">9</xref><xref ref-type="bibr" rid="ref16">16</xref><xref ref-type="bibr" rid="ref18">18</xref>&#x02013;<xref ref-type="bibr" rid="ref20">20</xref>] In our study, an initial dose of propofol was administered for 10 minutes both to allow for equivalent modes of dexmedetomidine and propofol administration and to minimize cardiovascular and respiratory depression related to the initial dose. Hypotension and bradycardia have been reported, particularly with large bolus dosing regimens, in patients with pre existing cardiac problems and in patients administered an initial dose in 10 minutes.[<xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref21">21</xref><xref ref-type="bibr" rid="ref23">23</xref>] Because decreases in MAP and HR with dexmedetomidine infusion were 20% of baseline and no bradycardia or hypotension occurred in any child because of the reason that we used initial bolus dose of dexmedetomidine intravenously over 10 minutes.</p><p>It has been reported that the decrease in MAP and HR after propofol induction was 15&#x02013;31% and 17&#x02013;24%, respectively.[<xref ref-type="bibr" rid="ref2">2</xref><xref ref-type="bibr" rid="ref17">17</xref><xref ref-type="bibr" rid="ref22">22</xref>] In our study, although MAP and HRdecreased significantly after dexmedetomidine and propofol infusion, the decrease in MAP was larger with propofol infusion. These decreases could have been exaggerated, because the patients were not pre medicated and the baseline values may have been high and not reflective of a time baseline value. Although at most time points, the decrease in MAP in the propofol group was more than that in dexmedetomidine group, only the decrease at 50 minutes was more than 20% of baseline. Respiratory events make up a large proportion (5.5%) of the complications of the sedation in children.[<xref ref-type="bibr" rid="ref4">4</xref>] Some authors have reported that dexmedetomidine did not affect RR, SpO2, and end-tidal carbondioxide (ETCO2).[<xref ref-type="bibr" rid="ref13">13</xref><xref ref-type="bibr" rid="ref24">24</xref>] However, some respiratory complications have been reported with large and rapid initial loading doses.[<xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref20">20</xref><xref ref-type="bibr" rid="ref25">25</xref>] When dexmedetomidine initial dose was administered rapidly (2 minutes), it caused irregular respiration, apnoea, slight hypoxemia, and hyper capnia.[<xref ref-type="bibr" rid="ref19">19</xref>] Propofol may depress ventilation, suppress pharyngeal and laryngeal reflexes, and cause transient apnoea.[<xref ref-type="bibr" rid="ref5">5</xref><xref ref-type="bibr" rid="ref10">10</xref><xref ref-type="bibr" rid="ref22">22</xref>] However, this is not a consistent finding.[<xref ref-type="bibr" rid="ref2">2</xref><xref ref-type="bibr" rid="ref11">11</xref>] In our study, the clinically insignificant decrease in RR during dexmedetomidine or propofol infusion may have been a result of high baseline values. Although RR decreased more with propofol than dexmedetomidine during sedation, and propofol was associated with more respiratory events, dexmedetomidine may provide more respiratory stability.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>Dexmedetomidine and propofol provided adequate sedation in most of the children aged between 1&#x02013;7 years. Although propofol provided more rapid rates of anesthetic induction and recovery, dexmedetomidine better preserved MAP and RR. Thus, dexmedetomidine could be an alternative sedative drug to propofol in selected patients.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson</surname><given-names>GR</given-names></name></person-group><article-title>Sedation of children for magnetic resonance imaging</article-title><source>Arch Dis Child</source><year>2000</year><volume>82</volume><fpage>150</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">10648372</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasan</surname><given-names>RA</given-names></name><name><surname>Shayevitz</surname><given-names>JR</given-names></name><name><surname>Patel</surname><given-names>V</given-names></name></person-group><article-title>Deep sedation with propofol for children undergoing ambulatory magnetic resonance imagingof the brain: Experience from a pediatric intensive care unit</article-title><source>Pediatr Crit Care Med</source><year>2003</year><volume>4</volume><fpage>454</fpage><lpage>8</lpage></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bluemke</surname><given-names>DA</given-names></name><name><surname>Breiter</surname><given-names>SN</given-names></name></person-group><article-title>Sedation procedures in MR imaging: safety, effectiveness, and nursing effect on examinations</article-title><source>Radiology</source><year>2000</year><volume>216</volume><fpage>645</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">10966690</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malviya</surname><given-names>S</given-names></name><name><surname>Voepel</surname><given-names>LT</given-names></name><name><surname>Eldevik</surname><given-names>OP</given-names></name><name><surname>Rockwell</surname><given-names>DT</given-names></name><name><surname>Wong</surname><given-names>JH</given-names></name><name><surname>Tait</surname><given-names>AR</given-names></name></person-group><article-title>Sedation and general anaesthesia in children undergoing MRI and CT: adverse eventsand outcomes</article-title><source>Br J Anaesth</source><year>2000</year><volume>84</volume><fpage>743</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10895749</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dial</surname><given-names>S</given-names></name><name><surname>Silver</surname><given-names>P</given-names></name><name><surname>Bock</surname><given-names>K</given-names></name><name><surname>Sagy</surname><given-names>M</given-names></name></person-group><article-title>Pediatric sedation for procedures titrated to desired degree of immobility results in unpredictabledepth of sedation</article-title><source>Pediatr Emerg Care</source><year>2001</year><volume>17</volume><fpage>414</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">11753184</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhana</surname><given-names>N</given-names></name><name><surname>Goa</surname><given-names>KL</given-names></name><name><surname>McClellan</surname><given-names>KJ</given-names></name></person-group><article-title>Dexmedetomidine</article-title><source>Drugs</source><year>2000</year><volume>59</volume><fpage>263</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10730549</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shelly</surname><given-names>MP</given-names></name></person-group><article-title>Dexmedetomidine: A real innovation or more of thesame?</article-title><source>Br J Anaesth</source><year>2001</year><volume>87</volume><fpage>677</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11878514</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>LE</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>T</given-names></name><name><surname>Saper</surname><given-names>CB</given-names></name><name><surname>Franks</surname><given-names>NP</given-names></name><name><surname>Maze</surname><given-names>M</given-names></name></person-group><article-title>The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleeppromotingpathway to exert its sedative effects</article-title><source>Anesthesiology</source><year>2003</year><volume>98</volume><fpage>428</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">12552203</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koroglu</surname><given-names>A</given-names></name><name><surname>Demirbilek</surname><given-names>S</given-names></name><name><surname>Teksan</surname><given-names>H</given-names></name><name><surname>Sagir</surname><given-names>O</given-names></name><name><surname>But</surname><given-names>AK</given-names></name><name><surname>Ersoy</surname><given-names>MO</given-names></name></person-group><article-title>Sedative, hemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: Preliminary results</article-title><source>Br J Anaesth</source><year>2005</year><volume>94</volume><fpage>821</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">15764627</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frankville</surname><given-names>DD</given-names></name><name><surname>Spear</surname><given-names>RM</given-names></name><name><surname>Dyck</surname><given-names>JB</given-names></name></person-group><article-title>The dose of propofol required to prevent children from moving during magneticresonance imaging</article-title><source>Anesthesiology</source><year>1993</year><volume>79</volume><fpage>953</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8239013</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usher</surname><given-names>GA</given-names></name><name><surname>Kearney</surname><given-names>RA</given-names></name><name><surname>Tsui</surname><given-names>BC</given-names></name></person-group><article-title>Propofol total intravenousanesthesia for MRI in children</article-title><source>Paediatr Anaesth</source><year>2005</year><volume>15</volume><fpage>23</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15649159</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voepel</surname><given-names>LT</given-names></name><name><surname>Malviya</surname><given-names>S</given-names></name><name><surname>Prochaska</surname><given-names>G</given-names></name><name><surname>Tait</surname><given-names>RA</given-names></name></person-group><article-title>Sedation failures in children undergoing MRI and CT: Is temperament a factor?</article-title><source>Paediatr Anaesth</source><year>2000</year><volume>10</volume><fpage>319</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">10792749</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>JE</given-names></name><name><surname>Ulrich</surname><given-names>TD</given-names></name><name><surname>Barney</surname><given-names>JA</given-names></name><name><surname>Arain</surname><given-names>SR</given-names></name><name><surname>Ebert</surname><given-names>TJ</given-names></name></person-group><article-title>Sedative, amnestic and analgesic properties of small-dose dexmedetomidine infusions</article-title><source>Anesth Analg</source><year>2000</year><volume>90</volume><fpage>699</fpage><lpage>705</lpage><pub-id pub-id-type="pmid">10702460</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobias</surname><given-names>JD</given-names></name><name><surname>Berkenbosch</surname><given-names>JW</given-names></name></person-group><article-title>Initial experience with dexmedetomidinesin paediatric-aged patients</article-title><source>Paediatr Anaesth</source><year>2002</year><volume>12</volume><fpage>171</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">11882231</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobias</surname><given-names>JD</given-names></name><name><surname>Berkenbosch</surname><given-names>JW</given-names></name><name><surname>Russo</surname><given-names>P</given-names></name></person-group><article-title>Additional experience with dexmedetomidine in pediatric patients</article-title><source>South Med J</source><year>2003</year><volume>96</volume><fpage>871</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">14513982</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Triltsch</surname><given-names>AE</given-names></name><name><surname>Welte</surname><given-names>M</given-names></name><name><surname>Von Homeyer</surname><given-names>P</given-names></name><name><surname>Grosse</surname><given-names>J</given-names></name><name><surname>Gen&#x000e4;hr</surname><given-names>A</given-names></name><name><surname>Moshirzadeh</surname><given-names>M</given-names></name><etal/></person-group><article-title>Bispectral indexguided sedation with dexmedetomidine in intensive care: randomized, double blind, placebo-controlled phase II study</article-title><source>Crit Care Med</source><year>2002</year><volume>30</volume><fpage>1007</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">12006795</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloomfield</surname><given-names>EL</given-names></name><name><surname>Masaryk</surname><given-names>TJ</given-names></name><name><surname>Caplin</surname><given-names>A</given-names></name><name><surname>Obuchowski</surname><given-names>NA</given-names></name><name><surname>Schubert</surname><given-names>A</given-names></name><name><surname>Hayden</surname><given-names>J</given-names></name><etal/></person-group><article-title>Intravenous sedation for MR imaging of the brain and spine in children:pentobarbital versus propofol</article-title><source>Radiology</source><year>1993</year><volume>186</volume><fpage>93</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8416594</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venn</surname><given-names>RM</given-names></name><name><surname>Bradshaw</surname><given-names>CJ</given-names></name><name><surname>Spencer</surname><given-names>R</given-names></name><name><surname>Brealey</surname><given-names>D</given-names></name><name><surname>Caudwell</surname><given-names>E</given-names></name><name><surname>Naughton</surname><given-names>C</given-names></name><etal/></person-group><article-title>Preliminary UK experience of dexmedetomidine, a novel agent for postoperativesedation in the intensive care unit</article-title><source>Anaesthesia</source><year>1999</year><volume>54</volume><fpage>1136</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">10594409</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebert</surname><given-names>TJ</given-names></name><name><surname>Hall</surname><given-names>JE</given-names></name><name><surname>Barney</surname><given-names>JA</given-names></name><name><surname>Uhrich</surname><given-names>TD</given-names></name><name><surname>Colinco</surname><given-names>MD</given-names></name></person-group><article-title>The effects of increasingplasma concentrations of dexmedetomidine in humans</article-title><source>Anesthesiology</source><year>2000</year><volume>93</volume><fpage>382</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">10910487</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venn</surname><given-names>RM</given-names></name><name><surname>Karol</surname><given-names>MD</given-names></name><name><surname>Grounds</surname><given-names>RM</given-names></name></person-group><article-title>Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patientsrequiring intensive care</article-title><source>Br J Anaesth</source><year>2002</year><volume>88</volume><fpage>669</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">12067004</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallio</surname><given-names>A</given-names></name><name><surname>Scheinin</surname><given-names>M</given-names></name><name><surname>Koulu</surname><given-names>M</given-names></name><name><surname>Ponkilainen</surname><given-names>R</given-names></name><name><surname>Ruskoaho</surname><given-names>H</given-names></name><name><surname>Viinam&#x000e4;ki</surname><given-names>O</given-names></name><etal/></person-group><article-title>Effects of dexmedetomidine, a selective alpha2-adrenoceptor agonist, on hemodynamic control mechanisms</article-title><source>Clin Pharmacol Ther</source><year>1989</year><volume>49</volume><fpage>33</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">2568211</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aun</surname><given-names>CS</given-names></name></person-group><article-title>New i.v. agents</article-title><source>Br J Anaesth</source><year>1999</year><volume>83</volume><fpage>29</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">10616331</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tramer</surname><given-names>MR</given-names></name><name><surname>Moore</surname><given-names>RA</given-names></name><name><surname>McQuay</surname><given-names>HJ</given-names></name></person-group><article-title>Propofol and bradycardia:causation, frequency and severity</article-title><source>Br J Anaesth</source><year>1997</year><volume>78</volume><fpage>642</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">9215013</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venn</surname><given-names>RM</given-names></name><name><surname>Hell</surname><given-names>J</given-names></name><name><surname>Grounds</surname><given-names>RM</given-names></name></person-group><article-title>Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care</article-title><source>Crit Care</source><year>2000</year><volume>4</volume><fpage>302</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11056756</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belleville</surname><given-names>JP</given-names></name><name><surname>Wards</surname><given-names>DS</given-names></name><name><surname>Bloor</surname><given-names>BC</given-names></name><name><surname>Maze</surname><given-names>M</given-names></name></person-group><article-title>Effects of intravenous dexmedetomidine in human: sedation, ventilation and metabolic rate</article-title><source>Anesthesiology</source><year>1992</year><volume>77</volume><fpage>1125</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">1361310</pub-id></element-citation></ref></ref-list></back></article>